{"id":"W2167555906","doi":"10.1200/jco.2005.05.016","title":"State-of-the-Art Therapeutics: Hodgkin's Lymphoma","year":2005,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Dacarbazine; Bleomycin; Vinblastine; Disease; Chemotherapy; Lymphoma; Internal medicine; Oncology; Adverse effect; Regimen; Radiation therapy; Surgery; Intensive care medicine; Vincristine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002359424,0.0003571139,0.00681086,0.0001547966,0.00003453244,0.000009031867,0.000435504,0.0007942741,0.0001515139],"category_scores_gemma":[0.0009097239,0.0001698407,0.004240632,0.0002094242,0.0003087526,0.0000496726,0.0001107295,0.0007531837,0.0001300032],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006488562,"about_ca_system_score_gemma":0.008008186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004150493,"about_ca_topic_score_gemma":0.00001193283,"domain_scores_codex":[0.9927027,0.0009635031,0.005236624,0.0002447945,0.0005699735,0.0002824265],"domain_scores_gemma":[0.9878857,0.004185861,0.006683307,0.0005133569,0.0004053524,0.0003264327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002638948,0.003577387,0.0007586218,0.0007548652,0.002696269,0.0004060271,0.00001530402,3.600057e-7,4.210777e-8,0.0000290358,0.007023898,0.9844743],"study_design_scores_gemma":[0.005399999,0.005672301,0.00460176,0.005598316,0.008580249,0.001609031,0.000003941689,0.000001076593,0.00000157728,0.00007337919,0.968331,0.0001273515],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004190184,0.9907482,0.000005357728,0.002156151,0.002431615,0.0005170302,0.00001427615,0.000006038483,0.003702323],"genre_scores_gemma":[0.000275982,0.9936444,0.001060188,0.001870608,0.001801536,0.00001324964,0.000004522545,0.00004289933,0.001286639],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9843469,"threshold_uncertainty_score":0.9976155,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2452571064447875,"score_gpt":0.5256802401579725,"score_spread":0.2804231337131851,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}